The novel JNK inhibitor AS602801 inhibits cancer stem cells <i>in vitro</i> and <i>in vivo</i>Masashi Okada, Chifumi Kitanaka, Kenta Kuramoto et al.|Oncotarget|2016Cited by 60
GSKJ4, A Selective Jumonji H3K27 Demethylase Inhibitor, Effectively Targets Ovarian Cancer Stem Cells.Hirotsugu Sakaki, Chifumi Kitanaka, Masashi Okada et al.|PubMed|2015Cited by 55
Aripiprazole, an Antipsychotic and Partial Dopamine Agonist, Inhibits Cancer Stem Cells and Reverses ChemoresistanceShuhei Suzuki, Chifumi Kitanaka, Masashi Okada et al.|Anticancer Research|2016Cited by 54
Rho-Associated Protein Kinase (ROCK) Inhibitors Inhibit Survivin Expression and Sensitize Pancreatic Cancer Stem Cells to GemcitabineHiroyuki Takeda, Chifumi Kitanaka, Masashi Okada et al.|Anticancer Research|2016Cited by 35
Impact of H3K27 Demethylase Inhibitor GSKJ4 on NSCLC Cells Alone and in Combination with MetforminHikaru Watarai, Chifumi Kitanaka, Masashi Okada et al.|Anticancer Research|2016Cited by 32